HUTCHMED (China) Ltd Files 6-K Report
Ticker: HMDCF · Form: 6-K · Filed: Sep 9, 2024 · CIK: 1648257
| Field | Detail |
|---|---|
| Company | Hutchmed (China) LTD (HMDCF) |
| Form Type | 6-K |
| Filed Date | Sep 9, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, routine-report
TL;DR
HUTCHMED (China) Ltd filed a standard 6-K report with the SEC on 9/9/24.
AI Summary
HUTCHMED (China) Limited filed a Form 6-K on September 9, 2024. This report is for the month of September 2024 and indicates the company files annual reports under Form 20-F. The company's principal executive offices are located in Hong Kong.
Why It Matters
This filing is a routine report for foreign private issuers, providing updates to the SEC. Investors should review the content for any material changes or announcements.
Risk Assessment
Risk Level: low — This is a routine filing and does not appear to contain significant new financial or operational information.
Key Players & Entities
- HUTCHMED (China) Limited (company) — Registrant
- 001-37710 (company) — SEC File Number
- 20240909 (date) — Filing Date
FAQ
What type of report is HUTCHMED (China) Limited filing?
HUTCHMED (China) Limited is filing a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
When was this Form 6-K filed?
This Form 6-K was filed on September 9, 2024.
Does HUTCHMED (China) Limited file annual reports under Form 20-F or 40-F?
The filing indicates that HUTCHMED (China) Limited files annual reports under cover of Form 20-F.
Where are HUTCHMED (China) Limited's principal executive offices located?
The principal executive offices of HUTCHMED (China) Limited are located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.
What is the SEC file number for HUTCHMED (China) Limited?
The SEC file number for HUTCHMED (China) Limited is 001-37710.
Filing Stats: 175 words · 1 min read · ~1 pages · Grade level 13.5 · Accepted 2024-09-09 06:13:19
Filing Documents
- hcm-20240909x6k.htm (6-K) — 20KB
- hcm-20240909xex99d1.htm (EX-99.1) — 56KB
- hcm-20240909xex99d1001.gif (GRAPHIC) — 4KB
- 0001648257-24-000074.txt ( ) — 82KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of September 2024 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Press release relating to HUTCHMED highlights clinical data to be presented at ESMO Congress 2024 and the 2024 World Conference of Lung Cancer 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: September 9, 2024 3